{"ticker": {"uuid": "b346bd0a-ce85-4beb-89c6-104a054bfddf", "symbol": "IMC", "name": "Immuron Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Immuron FY26 sales rise 6% to AUD$7.7 million led by Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPTlZkZDNMZ0o4OEE3bFJkVGZpSVNDQU8tWTNXTUxWSmloUEF0MUl4aFpuZlFxNVF0WHFqRkI4WEVKOE90LVBJa2VtaXFrMVBrMFZTdXVTaEIzN1RremFjekFLdU5oWUtsR21GMHdHemlLQ0hnVTNxNnJPWUF3UWVKZEQycGNoLTRfTFVTb0RWalpYUXhQNW42WG9WZDFDVlZqZGhSVGRjTU9McUJuRk9qZmtfOTJxU18yVGc?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-16T10:39:13+00:00", "published_display": "16 Jul 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron's Travelan Sales Grow for Four Straight Quarters", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZDlzUF9pa3kxLXkwMmFsVE9jSVgzcTVPN0lQcXc5UmNtbkR3MExMX0NQRDZfLTAxdmtSaU14VVdHenZLTXkxVUlpd2pIUVRhWjVzM3o4SzhOZ3hFbkNObUNkbDh4RTEtMDdPSDZRdUYwOXpxUG1SRW9MVVhrOGR3NFV6U2J2cV9YS2FlYzNWNGx5VUJ4eG8zV055ZldvZ1kwMkxVRi03cFJzc1JXeE1Id2dHbjV1SGtpNC1FSw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T10:00:00+00:00", "published_display": "16 Jul 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (ASX: IMC) Delivers Another Year of Sales Growth as Travelan Gains Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNR1pUdUpPQlVUSmp0M3V4bi1vb1B6eHZNYWFXOE15djM0QzdIWnc4LTJ3N3dfRGpfRHdtX3YzOURQS182WkVSS05IcFZZUEdvMnVBY0dwbkczdXFOR0JlOGE4ZUVlbzNiVktqb1Jxdm4wT1VJNmVCcnBwSTRxSVdPeGRMQVVTLXpLWExzaUZaLTJESXVYRVVrUTNNcXJXaDlGMVJRb05TWTJrNnlLdHpCNUhncW5hOUMyd1V5MUtZWFRqSkljUnc?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T06:22:00+00:00", "published_display": "16 Jul 2026 06:22", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australia's Immuron sales reach $7.7 million in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNSzF3MkhDc2hYZmpFQ0FvdU1pX1kwU2VlWHVNNVA3YVJlbm1KdGtiTmxKOGp5ZXdtZUZtM2FObWtIZm0tNVdoUnJ6Sk1ocnlKOGtkdV9YOElTOXh6bGFOMTZDTnFudmNScFFubzd4QlRBQmFpRl9VS25IY3ZVNFhUNg?oc=5", "source_name": "grafa.com", "published_at": "2026-07-16T02:32:17+00:00", "published_display": "16 Jul 2026 02:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (NASDAQ: IMRN) advances IMM-529 CDI drug with new partnering push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPYjNkSEI1VVR3U2s4UVdjR0x5azI5WFh6VmtyOXh5ay1YbDZwT1dMUVZOX0p1RlREYktTM3plU3VyVi1SNkVmODhpWTJlalROSTJzT05CazhWdlcwbXpaalNpclVjQ3ZzSU4xSEZjU3dDX0tMZms0blBBcHhRODBjY2dVOWptakNvOUlXVTNNM0M0c1J2dnVreHZ0VHE3R0RSSkM5ZlNuZXZqQTQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T12:01:45+00:00", "published_display": "06 Jul 2026 12:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPd0NtNk85OGY2QUxjRmUyQm54blZIWmxMeVMyTGVLemJLMU5oSDBWUHZMYi1QRHlFelkzSUE1bXlLSHVlTndOSWtlckJraE5JZEUybUwwblFiRFFRS2RPdFZDUDEtQkFPYVdWWnprZVhjdjQ1N0QyN1diSmJSVjJVRDdrb1Y2WmpsVHhzUDRRREx6b0l1bVBWSXRjN1dic2QwVjY2UEYwSDhNay11NDhKRWtEcG9pclVhVng5amJpMHZtSmRsZnp1Mjk2YWxRbHRXczdEQg?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-06T10:51:14+00:00", "published_display": "06 Jul 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron seeks partner for gut infection drug IMM-529", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPU3FRNVp1TDJsXzN6djBHeHJoa2MtNi01T2ctVFF1UnlwT2g1SS1zbDRxZnI2THVtMjdYYkI3a0VEdy1nRlR4MjNkOURkQUlKSVFoa0dHTEU0VVBCeE9XTWVHN0tHU2lrOG0tX2tVUjZOVEFOaGszQ1hxWFcwdkZVTEl3N0lPMWc5LUhpaXpnTFFmRVYtVEYwUlUydzQ1Q0kyakF4clR4WkxFckhCVzJhbUZPR2U?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (NASDAQ: IMRN) now has 322.8M ordinary shares on issue", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWTJBZVhFQXYzQXZ5TFFPR3dyMzVwa0RDTnc5X2ZLT25EbE1DQjQ1eHhwcnVyN3FWeEk1QTRWNk5GVGJJc0tNWExFbjJHaE54bm12eGJJa0hwR19sVVo2cm1SMmd1LU1hWHJHRmdVT3MtOFdyOElESFBuZ3hlRUFwNHJlaVJvSDVSOUxLN2lIdVFhWG00SkxGMnZDWTBhY1ZPTUhYa1R5NFZzdXM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (ASX: IMC): Advancing Gastrointestinal Product Portfolio Across Multiple Markets", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxONGgyczQ4aEpIUlZFWVJuMlgzYVdpc2lHQV9CZ3VIcmVsekxCM2JNM0otWDRYZlB6R2FmN1FldzFzYXRuYm1nTm1XVmpKcF9POGZ0RmxPMHdZaTI1Rzg1WnJQQUVEX1JOUUtCVUQ4andQbWlYRXpuNVJ3YU5BVDdPcVhZSkZ4VUdzU1JuZnlaNWNSY1UwUHpqNDVxX054Wl9xNmF2WE94aVhCOEk0ejJvMlRGUlR3MTZGYWNUckR5ZXNmQ0k3YnJvdlk2RQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (NASDAQ: IMRN) responds to ASX query on share price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQVpDWm05QVFiN0pIV1gxVW56Mkt4ZkI2V0FKc2ZzNkh2WEJHRkhlVnFES2FfQk1VVXdUcG44MG96eFRYeVkzODRHcE0tQ3dfSmxFUFBoVXN1RWhrQXNOX1FyVmc5akRRNEhjWGFSWFlfM1RMNm45U2hYd2ROT1pkWG1TQm1wZTR2WWNpaFREZ1B2TFZBUlhSd0p2andxR2YtdWRuUGNRQW9oX28?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Global Momentum Continues as Immuron Delivers Double-Digit Q3 Sales Growth in Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbDFzNUJOOEZvX2otU2h2RVFaS3g5VEtPcDZIVTlobThCZng3OUsyeFVPQnpzUUNtYTZnUlFfeFY4R3NvbU1ENDBEc3ZIUW5mQWVacElnZEMzSnYzeDNZSVNlMmVBQjVOMzV6M3hzdU5GaHpzZ3c2ZnpJYmI5VERMNDE3bjZmN0k3eGRLS0lnWGYwb3dWaUkyRzRIQ1cyUUw1T2ltME1xTFJuMzA5Mi1DV2MzeU1FTFAx?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Immuron Ltd (ASX:IMC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBQNFdCVjRaRV9mNlJVNTEzNmFuNG10Q1NadnZYZEFWdnpCa3VWUnAzTDhVZnFPV3p6UkV0T0tMWHJaWDAwLUJHaUxweE5hQ3Zk?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:44:57+00:00", "published_display": "30 Oct 2025 15:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron launches PROIBS in Australia to support people living with IBS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNd2xGVnhNUEtDU0NSYmFEa01QLUJHbmVQekF0TUUzX09NMnNHNGcxLTg3TDkxU1FsWnlXQkZHc2NaMnBuLTQ5RFdSWEFiUF9oLVNPS0FDV0R3bW9USFJFRUdwNjJwZVp3cVFWWUs0UUJwdEp4VmFyVVBBWFNMcGE0aGtHTGVrWXlXMENad041ekdicGRlYWpsRjRBbHRJcUJLQ1dhQkljRkJIZw?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron Limited (ASX: IMC) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRW9NRUk5c0xSbTY0SF9HTFJJUVJaYy1NMHcxLThWd3JBQTZDVXJFdWQwX1VwbVhVSnpQMFJIV09fbWZjb3hGQVFJYzBLeE5JQjdFTGJhbERNWXZlRXI0UGtoejdUMFl3THM2eklubXZlYWl2RjdVTHlYcklCVWJqTm0wVmpaVWwz?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-18T21:14:42+00:00", "published_display": "18 Feb 2020 21:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMC Stock Price and Chart \u2014 ASX:IMC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1JR2dtX2VoR1I4YUpsT3VZMnlYSkpQdktyYWdFZGUzbkpybFR2UHdpZDdNRmw0SnYwUVV6a0RTSU9sNlhsQkRHQlZkN0JCMkJwalJiYk5Scw?oc=5", "source_name": "TradingView", "published_at": "2017-07-20T03:43:54+00:00", "published_display": "20 Jul 2017 03:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Immuron FY26 sales rise 6% to AUD$7.7 million led by Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPTlZkZDNMZ0o4OEE3bFJkVGZpSVNDQU8tWTNXTUxWSmloUEF0MUl4aFpuZlFxNVF0WHFqRkI4WEVKOE90LVBJa2VtaXFrMVBrMFZTdXVTaEIzN1RremFjekFLdU5oWUtsR21GMHdHemlLQ0hnVTNxNnJPWUF3UWVKZEQycGNoLTRfTFVTb0RWalpYUXhQNW42WG9WZDFDVlZqZGhSVGRjTU9McUJuRk9qZmtfOTJxU18yVGc?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-16T10:39:13+00:00", "published_display": "16 Jul 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron's Travelan Sales Grow for Four Straight Quarters", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZDlzUF9pa3kxLXkwMmFsVE9jSVgzcTVPN0lQcXc5UmNtbkR3MExMX0NQRDZfLTAxdmtSaU14VVdHenZLTXkxVUlpd2pIUVRhWjVzM3o4SzhOZ3hFbkNObUNkbDh4RTEtMDdPSDZRdUYwOXpxUG1SRW9MVVhrOGR3NFV6U2J2cV9YS2FlYzNWNGx5VUJ4eG8zV055ZldvZ1kwMkxVRi03cFJzc1JXeE1Id2dHbjV1SGtpNC1FSw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T10:00:00+00:00", "published_display": "16 Jul 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (ASX: IMC) Delivers Another Year of Sales Growth as Travelan Gains Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNR1pUdUpPQlVUSmp0M3V4bi1vb1B6eHZNYWFXOE15djM0QzdIWnc4LTJ3N3dfRGpfRHdtX3YzOURQS182WkVSS05IcFZZUEdvMnVBY0dwbkczdXFOR0JlOGE4ZUVlbzNiVktqb1Jxdm4wT1VJNmVCcnBwSTRxSVdPeGRMQVVTLXpLWExzaUZaLTJESXVYRVVrUTNNcXJXaDlGMVJRb05TWTJrNnlLdHpCNUhncW5hOUMyd1V5MUtZWFRqSkljUnc?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T06:22:00+00:00", "published_display": "16 Jul 2026 06:22", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australia's Immuron sales reach $7.7 million in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNSzF3MkhDc2hYZmpFQ0FvdU1pX1kwU2VlWHVNNVA3YVJlbm1KdGtiTmxKOGp5ZXdtZUZtM2FObWtIZm0tNVdoUnJ6Sk1ocnlKOGtkdV9YOElTOXh6bGFOMTZDTnFudmNScFFubzd4QlRBQmFpRl9VS25IY3ZVNFhUNg?oc=5", "source_name": "grafa.com", "published_at": "2026-07-16T02:32:17+00:00", "published_display": "16 Jul 2026 02:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (NASDAQ: IMRN) advances IMM-529 CDI drug with new partnering push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPYjNkSEI1VVR3U2s4UVdjR0x5azI5WFh6VmtyOXh5ay1YbDZwT1dMUVZOX0p1RlREYktTM3plU3VyVi1SNkVmODhpWTJlalROSTJzT05CazhWdlcwbXpaalNpclVjQ3ZzSU4xSEZjU3dDX0tMZms0blBBcHhRODBjY2dVOWptakNvOUlXVTNNM0M0c1J2dnVreHZ0VHE3R0RSSkM5ZlNuZXZqQTQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T12:01:45+00:00", "published_display": "06 Jul 2026 12:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPd0NtNk85OGY2QUxjRmUyQm54blZIWmxMeVMyTGVLemJLMU5oSDBWUHZMYi1QRHlFelkzSUE1bXlLSHVlTndOSWtlckJraE5JZEUybUwwblFiRFFRS2RPdFZDUDEtQkFPYVdWWnprZVhjdjQ1N0QyN1diSmJSVjJVRDdrb1Y2WmpsVHhzUDRRREx6b0l1bVBWSXRjN1dic2QwVjY2UEYwSDhNay11NDhKRWtEcG9pclVhVng5amJpMHZtSmRsZnp1Mjk2YWxRbHRXczdEQg?oc=5", "source_name": "markets.businessinsider.com", "published_at": "2026-07-06T10:51:14+00:00", "published_display": "06 Jul 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron seeks partner for gut infection drug IMM-529", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPU3FRNVp1TDJsXzN6djBHeHJoa2MtNi01T2ctVFF1UnlwT2g1SS1zbDRxZnI2THVtMjdYYkI3a0VEdy1nRlR4MjNkOURkQUlKSVFoa0dHTEU0VVBCeE9XTWVHN0tHU2lrOG0tX2tVUjZOVEFOaGszQ1hxWFcwdkZVTEl3N0lPMWc5LUhpaXpnTFFmRVYtVEYwUlUydzQ1Q0kyakF4clR4WkxFckhCVzJhbUZPR2U?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (NASDAQ: IMRN) now has 322.8M ordinary shares on issue", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWTJBZVhFQXYzQXZ5TFFPR3dyMzVwa0RDTnc5X2ZLT25EbE1DQjQ1eHhwcnVyN3FWeEk1QTRWNk5GVGJJc0tNWExFbjJHaE54bm12eGJJa0hwR19sVVo2cm1SMmd1LU1hWHJHRmdVT3MtOFdyOElESFBuZ3hlRUFwNHJlaVJvSDVSOUxLN2lIdVFhWG00SkxGMnZDWTBhY1ZPTUhYa1R5NFZzdXM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (ASX: IMC): Advancing Gastrointestinal Product Portfolio Across Multiple Markets", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxONGgyczQ4aEpIUlZFWVJuMlgzYVdpc2lHQV9CZ3VIcmVsekxCM2JNM0otWDRYZlB6R2FmN1FldzFzYXRuYm1nTm1XVmpKcF9POGZ0RmxPMHdZaTI1Rzg1WnJQQUVEX1JOUUtCVUQ4andQbWlYRXpuNVJ3YU5BVDdPcVhZSkZ4VUdzU1JuZnlaNWNSY1UwUHpqNDVxX054Wl9xNmF2WE94aVhCOEk0ejJvMlRGUlR3MTZGYWNUckR5ZXNmQ0k3YnJvdlk2RQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron (NASDAQ: IMRN) responds to ASX query on share price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQVpDWm05QVFiN0pIV1gxVW56Mkt4ZkI2V0FKc2ZzNkh2WEJHRkhlVnFES2FfQk1VVXdUcG44MG96eFRYeVkzODRHcE0tQ3dfSmxFUFBoVXN1RWhrQXNOX1FyVmc5akRRNEhjWGFSWFlfM1RMNm45U2hYd2ROT1pkWG1TQm1wZTR2WWNpaFREZ1B2TFZBUlhSd0p2andxR2YtdWRuUGNRQW9oX28?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Global Momentum Continues as Immuron Delivers Double-Digit Q3 Sales Growth in Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbDFzNUJOOEZvX2otU2h2RVFaS3g5VEtPcDZIVTlobThCZng3OUsyeFVPQnpzUUNtYTZnUlFfeFY4R3NvbU1ENDBEc3ZIUW5mQWVacElnZEMzSnYzeDNZSVNlMmVBQjVOMzV6M3hzdU5GaHpzZ3c2ZnpJYmI5VERMNDE3bjZmN0k3eGRLS0lnWGYwb3dWaUkyRzRIQ1cyUUw1T2ltME1xTFJuMzA5Mi1DV2MzeU1FTFAx?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Immuron Ltd (ASX:IMC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBQNFdCVjRaRV9mNlJVNTEzNmFuNG10Q1NadnZYZEFWdnpCa3VWUnAzTDhVZnFPV3p6UkV0T0tMWHJaWDAwLUJHaUxweE5hQ3Zk?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:44:57+00:00", "published_display": "30 Oct 2025 15:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron launches PROIBS in Australia to support people living with IBS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNd2xGVnhNUEtDU0NSYmFEa01QLUJHbmVQekF0TUUzX09NMnNHNGcxLTg3TDkxU1FsWnlXQkZHc2NaMnBuLTQ5RFdSWEFiUF9oLVNPS0FDV0R3bW9USFJFRUdwNjJwZVp3cVFWWUs0UUJwdEp4VmFyVVBBWFNMcGE0aGtHTGVrWXlXMENad041ekdicGRlYWpsRjRBbHRJcUJLQ1dhQkljRkJIZw?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-10-27T07:00:00+00:00", "published_display": "27 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Immuron Limited (ASX: IMC) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRW9NRUk5c0xSbTY0SF9HTFJJUVJaYy1NMHcxLThWd3JBQTZDVXJFdWQwX1VwbVhVSnpQMFJIV09fbWZjb3hGQVFJYzBLeE5JQjdFTGJhbERNWXZlRXI0UGtoejdUMFl3THM2eklubXZlYWl2RjdVTHlYcklCVWJqTm0wVmpaVWwz?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-18T21:14:42+00:00", "published_display": "18 Feb 2020 21:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMC Stock Price and Chart \u2014 ASX:IMC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1JR2dtX2VoR1I4YUpsT3VZMnlYSkpQdktyYWdFZGUzbkpybFR2UHdpZDdNRmw0SnYwUVV6a0RTSU9sNlhsQkRHQlZkN0JCMkJwalJiYk5Scw?oc=5", "source_name": "TradingView", "published_at": "2017-07-20T03:43:54+00:00", "published_display": "20 Jul 2017 03:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 15, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 13, "score": 55, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 95, "events": [{"event": "general", "label": "Market update", "weight": 8.25, "count": 15}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.04, "latest_week": "2026-07-10", "one_week_move": 19.4, "four_week_move": 26.5, "twelve_week_move": 22.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.951375, "market_dynamics_buy_signal": false, "relative_strength": -13.515635, "fair_value_gap": -39.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.4615, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+19.4% over one week, +26.5% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 69, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 5}, {"label": "Kalkine Media", "count": 2}, {"label": "smallcaps.com.au", "count": 2}, {"label": "scanx.trade", "count": 1}, {"label": "grafa.com", "count": 1}, {"label": "markets.businessinsider.com", "count": 1}, {"label": "BiotechDispatch", "count": 1}, {"label": "intelligentinvestor.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "95/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+19.4% over one week, +26.5% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Immuron FY26 sales rise 6% to AUD$7.7 million led by Australia"}], "updated_at": "2026-07-16T22:24:27.604489+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}